{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:02:48Z","timestamp":1790877768800,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["217073\/Z\/19\/Z"],"award-info":[{"award-number":["217073\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221989\/Z\/20\/Z"],"award-info":[{"award-number":["221989\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225001\/Z\/22\/Z"],"award-info":[{"award-number":["225001\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00034\/6"],"award-info":[{"award-number":["MC_UU_00034\/6"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221989\/Z\/20\/Z"],"award-info":[{"award-number":["221989\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Serological data provide important insights into SARS-CoV-2 transmission and immunity, particularly in regions with limited routine surveillance such as sub-Saharan Africa. However, antibody waning and boosting following reinfection or vaccination remain poorly characterised, complicating interpretation of serological measurements. Improved understanding of these dynamics is critical for accurate epidemiological inference. Modelling longitudinal serological data provides a means to quantify antibody kinetics and reconstruct infection histories. We analysed 15,679 neutralising antibody (nAb) titres from 1,675 unvaccinated, HIV-uninfected participants in urban (Lilongwe) and rural (Karonga) Malawi (February 2021\u2013April 2022). NAb titres against ancestral B.1, Beta, Delta, and Omicron (BA.1\/BA.2) viruses were measured using an HIV-based SARS-CoV-2 pseudotyped virus neutralisation assay. A multi-level Bayesian model was used to reconstruct infection histories and antibody kinetics. The model identified 429 infections (95% credible interval 417\u2013441), including 39 (9.1%) that had not been identified by traditional seroconversion-based thresholds. Antibody levels waned rapidly, with 48% (0.403\u20130.560) of the acute boost remaining after three months and only 5% (0.027\u20130.098) after one year. Pre-Omicron infections generated stronger antibody boosts than Omicron infections. Responses varied, with individuals clustering into low and high responders. Cross-reactive responses extended across substantial antigenic distances - Omicron infections induced broader immunity. Seroincidence was higher in Lilongwe than in Karonga (0.41 vs. 0.27 infections per person per three months), driven by the early 2022 Omicron wave. Reinfections were common, particularly among adults and urban residents. SARS-CoV-2 nAb responses following infection were heterogeneous and declined rapidly. This rapid waning underscores the importance of vaccination for sustained protection, while cross-reactivity suggests only partial immunity from prior variants. Identifying reinfections is essential for understanding transmission and finding populations at higher repeat infection risk, particularly where routine surveillance is limited.<\/jats:p>","DOI":"10.1371\/journal.pgph.0007133","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:25:29Z","timestamp":1790875529000},"page":"e0007133","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 neutralising antibody profiles reveal variant specific antibody dynamics and regional differences in infection histories in Malawi"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-1265","authenticated-orcid":true,"given":"Mhairi J.","family":"McCormack","sequence":"first","affiliation":[{"name":"MRC-University of Glasgow Centre for Virus Research","place":["Glasgow, United Kingdom of Great Britain and Northern Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7108-5900","authenticated-orcid":true,"given":"Louis","family":"Banda","sequence":"additional","affiliation":[{"name":"Malawi Epidemiology and Intervention Research Unit (MEIRU)","place":["Karonga, Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-4122","authenticated-orcid":true,"given":"Stephen","family":"Kasenda","sequence":"additional","affiliation":[{"name":"Malawi Epidemiology and Intervention Research Unit (MEIRU)","place":["Karonga, Malawi"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen C.","family":"Hughes","sequence":"additional","affiliation":[{"name":"MRC-University of Glasgow Centre for Virus Research","place":["Glasgow, United Kingdom of Great Britain and Northern Ireland"]},{"name":"The Roslin Institute and R(D)SVS, University of Edinburgh","place":["Edinburgh, United Kingdom of Great Britain and Northern Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1513-4330","authenticated-orcid":true,"given":"Amelia","family":"Crampin","sequence":"additional","affiliation":[{"name":"Malawi Epidemiology and Intervention Research Unit (MEIRU)","place":["Karonga, Malawi"]},{"name":"University of Glasgow","place":["Glasgow, United Kingdom of Great Britain and Northern Ireland"],"department":["School of Health and Wellbeing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abena S.","family":"Amoah","sequence":"additional","affiliation":[{"name":"Malawi Epidemiology and Intervention Research Unit (MEIRU)","place":["Karonga, Malawi"]},{"name":"London School of Hygiene and Tropical Medicine","place":["London, United Kingdom of Great Britain and Northern Ireland"],"department":["Department of Population Health"]},{"name":"Leiden University Center for Infectious Diseases, Leiden University Medical Center","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-0962","authenticated-orcid":true,"given":"Jonathan M.","family":"Read","sequence":"additional","affiliation":[{"name":"Lancaster University","place":["Lancaster, United Kingdom of Great Britain and Northern Ireland"],"department":["Lancaster Medical School"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ho","sequence":"additional","affiliation":[{"name":"MRC-University of Glasgow Centre for Virus Research","place":["Glasgow, United Kingdom of Great Britain and Northern Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Willett","sequence":"additional","affiliation":[{"name":"MRC-University of Glasgow Centre for Virus Research","place":["Glasgow, United Kingdom of Great Britain and Northern Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1998-1844","authenticated-orcid":true,"given":"James A.","family":"Hay","sequence":"additional","affiliation":[{"name":"Pandemic Sciences Institute, University of Oxford","place":["Oxford, United Kingdom of Great Britain and Northern Ireland"],"department":["Nuffield Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"pgph.0007133.ref001","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00504-X","article-title":"Undetected COVID-19 cases in Africa","volume":"9","author":"TK Burki","year":"2021","journal-title":"Lancet Respir Med"},{"key":"pgph.0007133.ref002","unstructured":"Our World in Data. Total COVID-19 tests per 1,000 people. 2024 August 9 [cited 2026 March 2]. Available from: https:\/\/ourworldindata.org\/grapher\/full-list-cumulative-total-tests-per-thousand"},{"issue":"1","key":"pgph.0007133.ref003","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa599","article-title":"Viral ribonucleic acid shedding and transmission potential of asymptomatic and paucisymptomatic coronavirus disease 2019 patients","volume":"8","author":"A Samaddar","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"pgph.0007133.ref004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-008793","article-title":"SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021","volume":"7","author":"HC Lewis","year":"2022","journal-title":"BMJ Global Health"},{"key":"pgph.0007133.ref005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2023.10.020","article-title":"Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: a population-based cohort study","volume":"137","author":"L Banda","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"10","key":"pgph.0007133.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003474","article-title":"Controlling the first wave of the COVID-19 pandemic in Malawi: Results from a multi-round study","volume":"4","author":"J Banda","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"10","key":"pgph.0007133.ref007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003319","article-title":"Lockdown measures in response to COVID-19 in nine sub-Saharan African countries","volume":"5","author":"N Haider","year":"2020","journal-title":"BMJ Glob Health"},{"key":"pgph.0007133.ref008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijid.2021.12.336","article-title":"SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi","volume":"116","author":"C Meinus","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pgph.0007133.ref009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12916-021-02187-y","article-title":"SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021","volume":"19","author":"J Mandolo","year":"2021","journal-title":"BMC Med"},{"key":"pgph.0007133.ref010","doi-asserted-by":"crossref","first-page":"101800","DOI":"10.1016\/j.eclinm.2022.101800","article-title":"Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi","volume":"56","author":"UL Mseka","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"pgph.0007133.ref011","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41467-024-44973-1","article-title":"Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population","volume":"15","author":"J Wei","year":"2024","journal-title":"Nat Commun"},{"issue":"75","key":"pgph.0007133.ref012","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq4450","article-title":"Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct","volume":"7","author":"AZ Mykytyn","year":"2022","journal-title":"Sci Immunol"},{"key":"pgph.0007133.ref013","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00384-6","article-title":"Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1","volume":"4","author":"AZ Mykytyn","year":"2023","journal-title":"Lancet Microbe"},{"issue":"9","key":"pgph.0007133.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.07.018","article-title":"Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron","volume":"55","author":"K van der Straten","year":"2022","journal-title":"Immunity"},{"issue":"6666","key":"pgph.0007133.ref015","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj0070","article-title":"Mapping SARS-CoV-2 antigenic relationships and serological responses","volume":"382","author":"SH Wilks","year":"2023","journal-title":"Science"},{"issue":"1","key":"pgph.0007133.ref016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(24)00484-5","article-title":"Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: A mathematical modelling study","volume":"25","author":"TW Russell","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pgph.0007133.ref017","article-title":"An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver","volume":"16","author":"JA Hay","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"pgph.0007133.ref018","article-title":"Reconstructed influenza A\/H3N2 infection histories reveal variation in incidence and antibody dynamics over the life course","volume":"22","author":"JA Hay","year":"2024","journal-title":"PLoS Biol"},{"issue":"10","key":"pgph.0007133.ref019","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiaa338","article-title":"Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data","volume":"225","author":"A Minter","year":"2022","journal-title":"J Infect Dis"},{"issue":"659","key":"pgph.0007133.ref020","article-title":"SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron\u2019s impact in South African population cohorts","volume":"14","author":"K Sun","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"pgph.0007133.ref021","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1038\/s41467-021-26452-z","article-title":"Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels","volume":"12","author":"C Bottomley","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pgph.0007133.ref022","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/s41467-024-47556-2","article-title":"Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity","volume":"15","author":"S Merkt","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pgph.0007133.ref023","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41467-024-53727-y","article-title":"Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial","volume":"15","author":"LN Carpp","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"pgph.0007133.ref024","doi-asserted-by":"crossref","first-page":"37914","DOI":"10.1038\/s41598-025-22599-7","article-title":"Characterising protective immune responses to SARS-CoV-2 in urban and rural Malawi between February 2021 and April 2022","volume":"15","author":"MJ McCormack","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"pgph.0007133.ref025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/infdis\/jiaa788","article-title":"Severe acute respiratory syndrome coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting","volume":"223","author":"EC Hughes","year":"2021","journal-title":"J Infect Dis"},{"key":"pgph.0007133.ref026","doi-asserted-by":"crossref","unstructured":"Aragon TJ, Fay MP, Wollschlaeger D, Omidpanah A. epitools: Epidemiology Tools. R package version 0.5-10.1. 2020. https:\/\/doi.org\/10.32614\/CRAN.package.epitools","DOI":"10.32614\/CRAN.package.epitools"},{"issue":"1","key":"pgph.0007133.ref027","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-022-29310-8","article-title":"Reconstructing antibody dynamics to estimate the risk of influenza virus infection","volume":"13","author":"TK Tsang","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"pgph.0007133.ref028","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"BJ Willett","year":"2022","journal-title":"Nat Microbiol"},{"key":"pgph.0007133.ref029","unstructured":"Hodcroft EB. CoVariants: SARS-CoV-2 mutations and variants of interest. 2024 [Cited 2025 Nov 12]. Available from: https:\/\/covariants.org\/"},{"issue":"3","key":"pgph.0007133.ref030","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(20)30068-9","article-title":"COVID-19 testing in Africa: Lessons learnt","volume":"1","author":"P Ondoa","year":"2020","journal-title":"Lancet Microbe"},{"key":"pgph.0007133.ref031","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12992-022-00796-7","article-title":"The challenges of SARS-CoV-2 testing in low- and middle-income countries and possible cost-effective measures in resource-limited settings","volume":"18","author":"Z Duma","year":"2022","journal-title":"Glob Health"},{"issue":"1","key":"pgph.0007133.ref032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"EHY Lau","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"pgph.0007133.ref033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/jiaa673","article-title":"Neutralizing antibody responses in COVID-19 convalescent sera","volume":"223","author":"WT Lee","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"pgph.0007133.ref034","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1038\/s41467-022-32396-9","article-title":"Omicron BA.4\/BA.5 escape neutralizing immunity elicited by BA.1 infection","volume":"13","author":"K Khan","year":"2022","journal-title":"Nat Commun"},{"issue":"8","key":"pgph.0007133.ref035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/v15081661","article-title":"Increase in SARS-CoV-2 seroprevalence in UK domestic felids despite weak immunogenicity of post-omicron variants","volume":"15","author":"GB Tyson","year":"2023","journal-title":"Viruses"},{"key":"pgph.0007133.ref036","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq1841","article-title":"Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure","volume":"377","author":"CJ Reynolds","year":"2022","journal-title":"Science"},{"issue":"18","key":"pgph.0007133.ref037","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMc2211055","article-title":"Immune imprinting and protection against repeat reinfection with SARS-CoV-2","volume":"387","author":"H Chemaitelly","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"pgph.0007133.ref038","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/vaccines12070729","article-title":"Trichinella spiralis infection inhibits the efficacy of RBD protein of SARS-CoV-2 vaccination via regulating humoral and cellular immunity","volume":"12","author":"F Zhu","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pgph.0007133.ref039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molbiopara.2006.01.003","article-title":"IPSE\/alpha-1: a major immunogenic component secreted from Schistosoma mansoni eggs","volume":"147","author":"G Schramm","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"pgph.0007133.ref040","doi-asserted-by":"crossref","first-page":"1533102","DOI":"10.3389\/fimmu.2025.1533102","article-title":"Tracking the evolution of serum antibody levels and influencing factors post-SARS-CoV-2 infection among community residents in Fuzhou City","volume":"16","author":"X Zheng","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"pgph.0007133.ref041","article-title":"Association of age with SARS-CoV-2 antibody response","volume":"4","author":"HS Yang","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"pgph.0007133.ref042","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1002\/jmv.26939","article-title":"Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients","volume":"93","author":"M Teresa Valenzuela","year":"2021","journal-title":"J Med Virol"},{"issue":"30","key":"pgph.0007133.ref043","doi-asserted-by":"crossref","first-page":"40424","DOI":"10.1007\/s11356-021-12364-4","article-title":"Association between population density and infection rate suggests the importance of social distancing and travel restriction in reducing the COVID-19 pandemic","volume":"28","author":"H Yin","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"issue":"12","key":"pgph.0007133.ref044","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.3390\/ijerph19127439","article-title":"Correlation between population density and COVID-19 cases during the third wave in Malaysia: Effect of the delta Variant","volume":"19","author":"NH Md Iderus","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"pgph.0007133.ref045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78933","article-title":"COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)","volume":"11","author":"W Yang","year":"2022","journal-title":"Elife"},{"issue":"1","key":"pgph.0007133.ref046","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1038\/s41467-021-26479-2","article-title":"Anti-spike antibody response to natural SARS-CoV-2 infection in the general population","volume":"12","author":"J Wei","year":"2021","journal-title":"Nat Commun"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0007133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:25:39Z","timestamp":1790875539000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0007133"}},"subtitle":[],"editor":[{"given":"Shazia","family":"Ruybal-Pes\u00e1ntez","sequence":"first","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Imperial College London","place":["UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0007133","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}